Cargando…

Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1

Detalles Bibliográficos
Autores principales: Hiscox, S, Goddard, L, Jordan, N, Smith, C, Harper, M, Nicholson, RI, Gee, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300737/
http://dx.doi.org/10.1186/bcr1918
_version_ 1782226347400101888
author Hiscox, S
Goddard, L
Jordan, N
Smith, C
Harper, M
Nicholson, RI
Gee, J
author_facet Hiscox, S
Goddard, L
Jordan, N
Smith, C
Harper, M
Nicholson, RI
Gee, J
author_sort Hiscox, S
collection PubMed
description
format Online
Article
Text
id pubmed-3300737
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33007372012-03-14 Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1 Hiscox, S Goddard, L Jordan, N Smith, C Harper, M Nicholson, RI Gee, J Breast Cancer Res Poster Presentation BioMed Central 2008 2008-05-13 /pmc/articles/PMC3300737/ http://dx.doi.org/10.1186/bcr1918 Text en Copyright ©2008 BioMed Central Ltd
spellingShingle Poster Presentation
Hiscox, S
Goddard, L
Jordan, N
Smith, C
Harper, M
Nicholson, RI
Gee, J
Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
title Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
title_full Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
title_fullStr Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
title_full_unstemmed Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
title_short Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
title_sort overexpression of cd44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300737/
http://dx.doi.org/10.1186/bcr1918
work_keys_str_mv AT hiscoxs overexpressionofcd44inacquiredtamoxifenresistantbreastcancercellsaugmentstheirmigratoryresponsetoheregulinbeta1
AT goddardl overexpressionofcd44inacquiredtamoxifenresistantbreastcancercellsaugmentstheirmigratoryresponsetoheregulinbeta1
AT jordann overexpressionofcd44inacquiredtamoxifenresistantbreastcancercellsaugmentstheirmigratoryresponsetoheregulinbeta1
AT smithc overexpressionofcd44inacquiredtamoxifenresistantbreastcancercellsaugmentstheirmigratoryresponsetoheregulinbeta1
AT harperm overexpressionofcd44inacquiredtamoxifenresistantbreastcancercellsaugmentstheirmigratoryresponsetoheregulinbeta1
AT nicholsonri overexpressionofcd44inacquiredtamoxifenresistantbreastcancercellsaugmentstheirmigratoryresponsetoheregulinbeta1
AT geej overexpressionofcd44inacquiredtamoxifenresistantbreastcancercellsaugmentstheirmigratoryresponsetoheregulinbeta1